Grupo farmacéutico · Estados Unidos
AbbVie
Un grupo de 48 empresas con 954 medicamentos en 12 países.
Estructura del grupo
48 empresas en 20 países
Cargando la página…
Cargando la página…
Grupo farmacéutico · Estados Unidos
Un grupo de 48 empresas con 954 medicamentos en 12 países.
48 empresas en 20 países
Una cuenta gratuita para las apps de Prognia: Ward para estudiar, Osler para respuestas clínicas con sus fuentes y la red para encontrar a tus colegas.
Prognia forma los grupos a partir de los nombres que publican las autoridades reguladoras y de los vínculos entre empresas; no son una estructura societaria oficial.
Todos los medicamentos de todas las empresas del grupo, primero los vigentes.
1–25 de 954
| Medicamento | Principio activo | País | Estado | Autorización |
|---|---|---|---|---|
| ACTONEL35 mg · Tablet | Risedronate | Canadá | Comercializado | 2002 |
| ACTONEL150 mg · Tablet | Risedronate | Canadá | Comercializado | 2008 |
| ACTONEL DR35 mg · Tablet (Delayed-Release) | Risedronate | Canadá | Comercializado | 2011 |
| ACULAR | Ketorolac | Brasil | Autorizado | 1994 |
| ACULAR0.5 % / w/v · Solution | Ketorolac | Canadá | Comercializado | 1992 |
| ACULARCollirio, soluzione | Ketorolac | Italia | Autorizado | |
| ACULAR0.5% · Solution/drops | Ketorolac | Estados Unidos | Comercializado | 1992 |
| ACULAR 5 mg/ml COLIRIO EN SOLUCION5 mg · Colirio en solución | Ketorolac | España | Comercializado | 1997 |
| ACULAR LS0.4% · Solution/drops | Ketorolac | Estados Unidos | Comercializado | 2003 |
| ACULAR OPHTHALMIC SOLUTION 0.5%0.5% w/v · Solution | Ketorolac | Singapur | Autorizado | 1999 |
| ACULAR PRESERVATIVE FREE0.5% · Solution/drops | Ketorolac | Estados Unidos | No comercializado | 1997 |
| ACUVAIL0.45 % / w/v · Solution | Ketorolac | Canadá | Comercializado | 2012 |
| ACUVAIL0.45% · Solution/drops | Ketorolac | Estados Unidos | Comercializado | 2009 |
| ACYCLOVIR50mg base/ml · Injectable | Aciclovir | Estados Unidos | No comercializado | 1999 |
| AEROSEB-DEX0.01% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Aerosol | Dexamethasone | Estados Unidos | No comercializado | |
| AEROSEB-HC0.5% · Aerosol | Hydrocortisone | Estados Unidos | No comercializado | |
| AKINETON5mg/ml · Injectable | Biperiden | Estados Unidos | No comercializado | 1961 |
| AKINETON2MG · Tablet | Biperiden | Estados Unidos | No comercializado | 1959 |
| ALBALON0.1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Solution/drops | Naphazoline | Estados Unidos | No comercializado | 1972 |
| ALOCRIL2% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Solution/drops | Nedocromil | Estados Unidos | No comercializado | 1999 |
| ALORA0.025mg/24hr | 0.05mg/24hr | 0.075mg/24hr | 0.1mg/24hr · Film, extended release | Estradiol | Estados Unidos | Comercializado | 1996 |
| ALPHAGAN | Tartarato brimonidina | Brasil | Autorizado | 1997 |
| ALPHAGANCollirio, soluzione | Brimonidine | Italia | Autorizado | |
| ALPHAGAN0.2 % / w/v · Solution | Brimonidine | Canadá | Comercializado | 1997 |
| ALPHAGAN0.2% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 0.5% · Solution/drops | Brimonidine | Estados Unidos | No comercializado | 1996 |
Dónde es titular o fabricante de medicamentos, y cuántos están vigentes.
| País | Medicamentos | Vigentes | Anteriores | Empresas |
|---|---|---|---|---|
| Estados Unidos | 243 | 243 | 0 | EmpresasTodos los medicamentos |
| Canadá | 217 | 110 | 107 | EmpresasTodos los medicamentos |
| Brasil | 110 | 33 | 77 | EmpresasTodos los medicamentos |
| España | 100 | 76 | 24 | EmpresasTodos los medicamentos |
| Países Bajos | 56 | 56 | 0 | EmpresasTodos los medicamentos |
| Arabia Saudí | 55 | 55 | 0 | EmpresasTodos los medicamentos |
| Singapur | 45 | 45 | 0 | EmpresasTodos los medicamentos |
| Italia | 31 | 31 | 0 | EmpresasTodos los medicamentos |
| Rumanía | 31 | 0 | 31 | EmpresasTodos los medicamentos |
| Serbia | 30 | 30 | 0 | EmpresasTodos los medicamentos |
| Unión Europea (EMA) | 24 | 15 | 9 | EmpresasTodos los medicamentos |
| Croacia | 12 | 12 | 0 | EmpresasTodos los medicamentos |
También en los registros de Francia, Reino Unido
Los grupos ATC a los que pertenecen la mayoría de sus medicamentos, de mayor a menor.
Los principios activos presentes en la mayoría de sus medicamentos.
Cómo lo escriben los registros, normalizado: sin forma jurídica, tildes ni mayúsculas.
Recopilado por Prognia a partir de los registros públicos de medicamentos y empresas que aparecen abajo. No se usan logotipos.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Source: European Medicines Agency (EPAR data).
Licencia: EMA reuse policy (source acknowledgement required)
Fuente de la información: AEMPS (CIMA).
Licencia: AEMPS open data reuse with attribution
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licencia: Public domain (U.S. Government work)
Source: BDPM (ANSM, HAS, UNCAM).
Licencia: Licence Ouverte v1.0
ANVISA / CMED, consumer price table; embedded source date 2026-07-21 and retrieval date
Licencia: Other (Public Domain)
Anvisa published factual open-data CSV https://dados.anvisa.gov.br/dados/CONSULTAS/PRODUTOS/TA_CONSULTA_MEDICAMENTOS.CSV, HTTP version Mon, 12 Oct 2026 11:45:25 GMT; acquired 12 October 2026; original source states and timestamps retained.
Licencia: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licencia: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licencia: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licencia: Open Government Licence Canada
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licencia: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licencia: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained
Licencia: BDPM exact Licence Ouverte v1.0 (October 2011)
Companies House, Find and update company information; exact company number and page URL, accessed 8 October 2026. Structured factual extraction by Prognia. Crown-created website material under OGL 3.0: https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/.
Licencia: Companies House statutory public-register use; OGL 3.0 for Crown-created website material
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licencia: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licencia: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
GLEIF; exact source URLs/locators, version status and retrieval dates. Normalized by Prognia; no official endorsement.
Licencia: CC0
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licencia: Otvorena dozvola RH
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/847386/OFFICINE_API_GIUGNO_2025.csv; HTTP Last-Modified Tue, 08 Jul 2025 11:28:20 GMT; acquired 2026-10-13T17:21:05.497592+00:00; native fields retained, source identifier and role projections are adaptations.
Licencia: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_A_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:41 GMT; acquired 2026-10-13T17:21:06.055244+00:00; native fields retained, source identifier and role projections are adaptations.
Licencia: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_H_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:40 GMT; acquired 2026-10-13T17:21:06.034935+00:00; native fields retained, source identifier and role projections are adaptations.
Licencia: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/847386/officine_autorizzate_medicinali_30.06.2026.csv; HTTP Last-Modified Wed, 01 Jul 2026 09:37:30 GMT; acquired 2026-10-13T17:21:05.166252+00:00; native fields retained, source identifier and role projections are adaptations.
Licencia: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licencia: CC BY 4.0; AIFA published open-data catalog
Ministero della Salute, Italy; https://www.dati.salute.gov.it/it/dataset/distributori-di-farmaci/; original CSV snapshot 15 October 2026, acquired 2026-10-15T13:26:43.659718+00:00; adapted factual fields under IODL2. Coordinates: © OpenStreetMap contributors, separate rights gate.
Licencia: Italian Open Data Licence v2.0, exact dataset-catalog assignment; coordinate fields separately attributed to OpenStreetMap
Ministero della Salute, Distributori di farmaci, source file13Oct2026. https://www.dati.salute.gov.it/it/dataset/distributori-di-farmaci/; IODL2.0 https://www.dati.gov.it/content/italian-open-data-license-v20. Original URLs/locators and retrieval timestamps; selected/normalized by Prognia; no government endorsement.
Licencia: Italian Open Data Licence
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licencia: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Ministerul Sănătății, Catalogul public naţional al preţurilor, 18 iunie 2021, downloaded 2026-10-08 from data.gov.ro; CC BY 4.0; structured factual adaptation, code whitespace trimmed only where explicitly recorded.
Licencia: Creative Commons Attribution 4.0 International (CC BY 4.0)
ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.
Licencia: Serbian Open Data Licence (sodl)
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licencia: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Contains information from ACRA Information on Corporate Entities, accessed on 8 October 2026 through Data.gov.sg, under Singapore Open Data Licence version 1.0: https://data.gov.sg/open-data-licence. Structured selection and normalisation by Prognia; original UEN, field and retrieval date retained.
Licencia: Singapore Open Data Licence
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licencia: Singapore Open Data Licence
Register právnických osôb, podnikateľov a orgánov verejnej moci; public API licence names Štatistický úrad Slovenskej republiky; administration transferred to Ministerstvo vnútra SR; original API URL, literal identifier and source locators, source version and retrieval date; https://creativecommons.org/licenses/by/4.0/; normalization identified.
Licencia: Creative Commons Attribution
Slovak Ministry of Finance, Register účtovných závierok (RÚZ) Open API; exact IČO/accounting-unit, filing, report and template IDs; original API URLs, source locators and retrieval dates; https://www.registeruz.sk/cruz-public/home/api; extraction/normalization stated.
Licencia: CC0
FDA Purple Book, September 2026 release; acquired 2026-10-10T15:29:54.330165+00:00; exact source fields retained with source-key projections.
Licencia: FDA-created structured factual administrative metadata; public-domain policy with third-party exceptions
Informa de un error o solicita la retiradaLas correcciones de la propia empresa son bienvenidas.
Mantenga correctos los medicamentos de AbbVie en Prognia, vea cómo los consultan los profesionales y responda a lo que preguntan. Una llamada de 20 minutos, en inglés.
Reservar una llamadaGrupos farmacéuticos conocidos, cada uno con todas sus empresas.
Ordenados por su número de medicamentos.